178 related articles for article (PubMed ID: 31498712)
1. Controversies in locoregional management of breast cancer with low volume pN0(i+) and pN1mi nodal disease.
Dosani M; Truong PT
Expert Rev Anticancer Ther; 2019 Sep; 19(9):803-810. PubMed ID: 31498712
[No Abstract] [Full Text] [Related]
2. Can axillary node dissection be safely omitted in the elderly? A retrospective study on axillary management of early breast cancer in older women.
Esposito E; Sollazzo V; Di Micco R; Cervotti M; Luglio G; Benassai G; Mozzillo P; Perrotta S; Desiato V; Amato B; Forestieri P; Limite G
Int J Surg; 2016 Sep; 33 Suppl 1():S114-8. PubMed ID: 27353842
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer.
Madsen EV; Elias SG; van Dalen T; van Oort PM; van Gorp J; Gobardhan PD; Bongers V
Breast; 2013 Oct; 22(5):748-52. PubMed ID: 23313060
[TBL] [Abstract][Full Text] [Related]
4. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node treatment in breast cancer: an update.
Williams PA; Suggs J; Mangana SH
J Miss State Med Assoc; 2014 May; 55(5):145-7. PubMed ID: 25112128
[TBL] [Abstract][Full Text] [Related]
6. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
7. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
[TBL] [Abstract][Full Text] [Related]
8. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
9. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
10. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
11. Pathologic Evaluation and Prognostic Implications of Nodal Micrometastases in Breast Cancer.
Dutta SW; Volaric A; Morgan JT; Chinn Z; Atkins KA; Janowski EM
Semin Radiat Oncol; 2019 Apr; 29(2):102-110. PubMed ID: 30827448
[TBL] [Abstract][Full Text] [Related]
12. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
13. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
[TBL] [Abstract][Full Text] [Related]
14. Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.
Zetterlund L; Celebioglu F; Axelsson R; de Boniface J; Frisell J
Breast Cancer Res Treat; 2017 May; 163(1):93-101. PubMed ID: 28213781
[TBL] [Abstract][Full Text] [Related]
15. Comparable survival between pN0 breast cancer patients undergoing sentinel node biopsy and extensive axillary dissection: a report from the Korean Breast Cancer Society.
Moon HG; Han W; Noh DY
J Clin Oncol; 2010 Apr; 28(10):1692-9. PubMed ID: 20194848
[TBL] [Abstract][Full Text] [Related]
16. Omission of axillary lymph node dissection in breast cancer patients with micrometastasis or isolated tumor cells in sentinel lymph nodes: a 12-year experience in a tertiary breast unit.
Sousa N; Peleteiro B; Fougo JL
J Cancer Res Clin Oncol; 2023 Dec; 150(1):1. PubMed ID: 38153534
[TBL] [Abstract][Full Text] [Related]
17. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
18. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.
Zetterlund LH; Frisell J; Zouzos A; Axelsson R; Hatschek T; de Boniface J; Celebioglu F
Breast Cancer Res Treat; 2017 May; 163(1):103-110. PubMed ID: 28224384
[TBL] [Abstract][Full Text] [Related]
19. Can axillary node dissection be omitted in a subset of patients with low local and regional failure rates?
Barkley C; Burstein H; Smith B; Bellon J; Wong J; Gadd M; Taghian A; Winer E; Iglehart JD; Harris J; Golshan M
Breast J; 2012; 18(1):23-7. PubMed ID: 22017599
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in breast cancer New indications and our experience.
Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
